Dietary approaches offer significant advantages
If you are pregnant, nursing, under 18, or have a medical condition, consult your healthcare professional before use
The announcement this week follows several new initiatives designed to support startups within the University of Chicago ecosystem, including the new UChicago Science Incubator
Human clinical trials, though limited, have demonstrated a potential decrease in substance use among patients treated with GLP-1RAs, particularly for alcohol and tobacco use disorders
This reduces discomfort and potential irritation, and decreases the incidence of broken brackets by 49%* on average
In trials, tirzepatide and retatrutide had slightly higher rates of GI effects than semaglutide due to the additional pathway activation